Welcome to Francis Academic Press

Frontiers in Sport Research, 2021, 3(4); doi: 10.25236/FSR.2021.030405.

Mechanism of SIRT1-mediated Energy Deprivation (Calorie Restriction and Exercise) Against Sarcopenia


Wang Jinyue

Corresponding Author:
Wang Jinyue

Department of Physical Education, Foshan University, Foshan City, China


BACKGROUND: Sarcopenia is a symptom of muscle aging characterized by mass loss and strength loss. The disorder is the leading cause of fall incapacity/death in the elderly and the great enemy of healthy aging. Energy deprivation (calorie restriction and exercise) is the most effective means against aging and SIRT1 is a key mediator molecule. OBJECTIVE: The article summarizes and analyzes the mechanisms of SIRT1-mediated energy deprivation against sarcopenia/skeletal muscle aging. METHODS: Literature review. CONCLUSIONS: Exercise and Calorie restriction lead to intermittent and continuous energy deprivation in muscle, respectively, which may contribute to some differences in their effects and mechanisms. SIRT1 may reside centrally in energy deprivation against sarcopenia. AMPK/NAD+ is the bridge between energy deprivation and SIRT1 activation. SIRT1 downstream is mainly through four pathways (FOXO1/autophagy, PGC-1α/mitochondrial generation, P53/apoptosis and DNA repair, and NF-κB/inflammation) to antagonize muscle aging/sarcopenia. Future directions to focus on: (1) Difference between the mechanisms of SIRT1 under stresses of exercise and calorie restriction. (2) The role of non-transcription factor targets of SIRT1 such as eNOS, LKB1, etc. 3) Exact division of labor involved in several cellular event molecules simultaneously, such as FOXO1, NF-κB and P53.


SIRT1, Sarcopenia, Calorie restriction, Exercise, Skeletal muscle, Aging

Cite This Paper

Wang Jinyue. Mechanism of SIRT1-mediated Energy Deprivation (Calorie Restriction and Exercise) Against Sarcopenia. Frontiers in Sport Research (2021) Vol. 3, Issue 4: 19-22. https://doi.org/10.25236/FSR.2021.030405.


[1] Wang, J. (2016) Transforming growth factor-β and muscle regulation. Chinese Journal of Tissue Engineering Research, 20, 4979-4983

[2] Wang, J. (2016)The effect of sarcopenia on skeletal muscle, molecular mechanism and its prevention and treatment. Chinese Journal of Tissue Engineering Research, 29, 3932-3937

[3] Chen, C., Zhou, M., Ge, Y. (2020) SIRT1 and aging related signaling pathways. Mech Ageing Dev, 187,212-219

[4] Guo, J., Zhao, W., Cao, X. (2017) SIRT1 promotes tumor-like invasion of fibroblast-like synoviocytes in rheumatoid arthritis via targeting TIMP1. Oncotarget, 8, 88965-88973

[5] Donato, A.J., Magerko, K.A., Lawson, B.R. (2011) SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans. J Physiol, 589, 4545-4554

[6] Matt, K., Hochecker, B., Scholler-Mann, A. (2020) mRNA expression of ageing-associated genes in calorie reduction is subject to donor variability and can be induced by calorie restriction mimetics. Nutr Health, 26, 253-262

[7] Chandramowlishwaran, P., Vijay, A., Abraham, D. (2020) Role of Sirtuins in Modulating Neurodegeneration of the Enteric Nervous System and Central Nervous System. Front Neurosci, 14,614331-614345

[8] Hoong, C.W.S., and Chua, M.W.J. (2021) SGLT2 Inhibitors as Calorie Restriction Mimetics: Insights on Longevity Pathways and Age-Related Diseases. Endocrinology,162,513-525

[9] Draznin, B., Wang, C., Adochio, R. (2012) Effect of dietary macronutrient composition on AMPK and SIRT1 expression and activity in human skeletal muscle. Horm Metab Res, 44, 650-655

[10] Steinberg, G.R., and Kemp, B.E. (2009) AMPK in Health and Disease. Physiol Rev, 89,1025-1078

[11] Mo, C., Wang, L., Zhang, J. (2014) The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice [J]. Antioxid Redox Signal, 20, 574-588

[12] Chen, C., Ju, R., Zhu, L.(2017) Carboxyamidotriazole alleviates muscle atrophy in tumor-bearing mice by inhibiting NF-kappaB and activating SIRT1. Naunyn Schmiedebergs Arch Pharmacol, 390, 423-433